Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Director/PDMR Shareholding

6 Dec 2021 07:00

RNS Number : 5779U
Helios Underwriting Plc
06 December 2021
 

 

Helios Underwriting plc

("Helios", "Company" or the "Group")

 

Director's Shareholding 

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, was informed on 3 December 2021 that, on the same day, The 1609 Fund Ltd, which is under the management of ILS Capital Management Ltd, a Company which Tom Libassi, Non-Executive Director of the Company, co-founded and is managing partner of, purchased 15,000 ordinary shares of 10 pence each ("Ordinary Shares") in the Company at 168.67 pence each. Mr Libassi is also a director of The 1609 Fund Ltd.

Following the completion of the above transaction, funds under management of, or associated with, ILS Capital Management Ltd, hold in aggregate 13,362,000 Ordinary Shares, representing approximately 19.4 per cent. of the Company's total voting rights.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the transaction.

 

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £137m of capacity for the 2021 account based on the LLV acquisitions completed to date in 2021. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Tom Libassi

2

Reason for the notification

a)

Position/status

 

Non-Executive Director, a PDMR of the issuer

b)

Initial notification/Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary Shares of 10 pence each

 

ISIN - GB00B23XLS45

b)

Nature of the transaction

 

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

   

Price(s)

Volume(s)

Purchase: 168.67

15,000

 

d)

Aggregated information

 

Price(s)

Volume(s)

Purchase: as above

As above

 

e)

Date of the transaction

 

3 December 2021

f)

Place of the transaction  

 

London Stock Exchange, AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQXLFBFLLXFBL
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.